A recent survey, done by cardinal health found that the good number of oncologist’s relay on pharma sales representatives to gain the knowledge about new products and drug data. Apart from the new product education, pharma reps also add value by providing patient access and assistance programs, providing staff education and patient education materials. As per the survey, the oncologists prefer the pharmaceutical companies to provide the content beyond clinical and safety trial data by focussing up on patient outcome studies based on real-world evidence and drug comparative effectiveness studies.
Source – Policy and Medicine